🫀 Cardiology Update: Home Rehab Gains Ground, FDA Backs Artificial Heart, Cannabis Risk Revealed and More
From FDA-recognized artificial hearts to home-based rehab transforming recovery, this week’s cardiovascular roundup dives into the latest game-changing innovations, clinical findings, and product launches shaping the future of heart and brain health.
📌 In This Episode:
✔️Home-Based Cardiac Rehabilitation Matches In-Hospital Outcomes While Lowering Costs
✔️ BiVACOR’s Magnetically Levitated Artificial Heart Receives FDA Breakthrough Status
✔️ Edible Cannabis Linked to Significant Vascular Function Decline in New Study
✔️ Basic Mobile Phone Program Dramatically Improves Blood Pressure Control Post-Stroke
✔️ Terumo Debuts SOFIA Flow 88 Neurovascular Catheter in EMEA Region
✔️ Philips Launches SmartCT for Real-Time Stroke Imaging in Europe
✔️ Stroke Risk After Hemodialysis Shows Variation by Sex and Race
✔️ First International Guideline Released for Post-Stroke Visual Impairment Care
✔️ Standardized TAVR Protocols Lead to Safer, More Effective Patient Outcomes
✔️ Glymphatic Biomarker Identified as Predictor of Post-Stroke Cognitive Recovery
Whether you’re a clinician, researcher, or healthcare innovator, these updates provide valuable insight into where cardiovascular care is headed next.
📢 Stay Ahead in Cardiovascular Research!
✅ Like, share, and subscribe for weekly updates on Cardiovascular breakthroughs
#Cardiovascular #StrokeRecovery #ArtificialHeart #HeartHealth #MedicalInnovation #HealthcareNews #TAVR #Telehealth #GlymphaticSystem #CannabisResearch #Neurovascular #ClinicalResearch #LucidQuest